ContraFect News

Company Name Stock Ticker Symbol Market Type
ContraFect Corporation CFRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0267 -28.99% 0.0654 19:59:54
Open Price Low Price High Price Close Price Prev Close
0.0739 0.0631 0.074 0.0685 0.0921
more quote information »

Recent News

Date Time Source Heading
1/26/202317:02EDGARCurrent Report Filing (8-k)
1/03/202307:06EDGARProxy Statement (definitive) (def 14a)
12/23/202206:03EDGARProxy Statement - Notice of Shareholders Meeting..
12/19/202216:30GLOBEContraFect Provides Update from the Futility Analysis of the..
12/14/202217:22EDGARCurrent Report Filing (8-k)
12/13/202208:01GLOBEContraFect Announces Pricing of $7.0 Million Registered..
11/28/202208:00GLOBEContraFect Announces ANSM Approval of Clinical Trial..
11/25/202216:03EDGARCurrent Report Filing (8-k)
11/17/202223:35TRMNSVB Securities Remains a Hold on ContraFect (CFRX)
11/14/202216:47EDGARQuarterly Report (10-q)
11/14/202208:00GLOBEContraFect Reports Third Quarter 2022 Financial Results and..
9/12/202207:32GLOBEContraFect Announces Multiple Publications Highlighting the..
9/12/202207:30GLOBEContraFect Announces Presentation of New Clinical Data From..
8/31/202216:06EDGARCurrent Report Filing (8-k)
8/17/202222:36TRMNSVB Securities Sticks to Their Hold Rating for ContraFect..
8/16/202217:11EDGARCurrent Report Filing (8-k)
8/15/202218:13EDGARQuarterly Report (10-q)
8/15/202218:00EDGARCurrent Report Filing (8-k)
8/15/202208:30GLOBEContraFect Reports Second Quarter 2022 Financial Results and..
8/15/202208:25GLOBEContraFect Announces Publication on Exebacase and CF-296..
7/19/202217:14EDGARAmended Statement of Ownership (sc 13g/a)
7/13/202217:04EDGARCurrent Report Filing (8-k)
7/13/202216:05GLOBEContraFect Announces Independent DSMB Recommends Exebacase..
6/14/202207:30GLOBEPresentations at ASM Microbe Conference Demonstrate..
6/08/202208:37TRMNContraFect (CFRX) Received its Third Buy in a Row
6/06/202207:30GLOBEContraFect to Present Data Demonstrating the Potential of..
5/23/202216:35EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/23/202216:32EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/20/202208:30GLOBEContraFect Announces Inducement Grants Under Nasdaq Listing..
5/19/202217:02EDGARCurrent Report Filing (8-k)
5/18/202218:11EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202218:05EDGARStatement of Changes in Beneficial Ownership (4)
5/18/202208:34EDGARCurrent Report Filing (8-k)
5/17/202222:36TRMNSVB Securities Reiterates a Buy Rating on ContraFect (CFRX)
5/17/202211:15TRMNContraFect (CFRX) Gets a Buy Rating from Mizuho Securities
5/16/202218:07EDGARQuarterly Report (10-q)
5/16/202217:26EDGARCurrent Report Filing (8-k)
5/16/202207:30GLOBEContraFect Reports First Quarter 2022 Financial Results and..
4/27/202208:00GLOBEContraFect Data Presentations at the 32nd Annual ECCMID..
4/18/202207:30GLOBEContraFect Announces Multiple Presentations of New Data..
4/07/202223:37TRMNLeerink Partners Sticks to Their Buy Rating for ContraFect..
3/31/202217:15EDGARProxy Statement (definitive) (def 14a)
3/28/202220:38TRMNContraFect (CFRX) Gets a Buy Rating from Mizuho Securities
3/25/202211:57TRMNLeerink Partners Keeps a Buy Rating on ContraFect (CFRX)
3/25/202206:03EDGARAnnual Report (10-k)
3/24/202209:04SEEKContrafect GAAP EPS of -$0.11 beats by $0.19
3/24/202208:00GLOBEContraFect Reports Fourth Quarter 2021 and Full Year 2021..
3/21/202208:30GLOBEContraFect to Present at the Maxim Group 2022 Virtual Growth..
2/17/202218:19EDGARStatement of Changes in Beneficial Ownership (4)
2/17/202218:14EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230128 07:38:38